LENZ Therapeutics Inc (LENZ)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $120.03M
Last updated: Nov 17, 2026 at 4:43 PM ET
LENZ Therapeutics Inc (LENZ) Stock Chart
LENZ Therapeutics (LENZ) has a latest price of $3.50 on Nov 17, 2026, 89.1% below its 52-week high of $32.13. Its price fell 86.3% over the past 12 months. The month-end price fell 96.6% over the 5 years through Oct 2026, a compound annual decline of 49.1%.
Price Chart
From Jun 2021 to Oct 2026, its highest month-end close was $215.05 in Jun 2021 and its lowest $3.05 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart LENZ with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for LENZ.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 28.9%, and over 6 months it fell 47.4%. The month-end price fell 82.5% over the 3 years through Oct 2026, a compound annual decline of 44.1%.
| Period | Change |
|---|---|
| 1 month | +6.1% |
| 3 months | -28.9% |
| 6 months | -47.4% |
| 12 months | -86.3% |
| 12 months, with dividends | -86.3% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -82.5% | -44.1% |
| 5 years | -96.6% | -49.1% |
Price by Year
Its best calendar year was 2024, when the price rose 57.5%, and its weakest was 2022, when it fell 73.3%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $3.05 | -80.9% |
| 2025 | $16.00 | -44.6% |
| 2024 | $28.87 | +57.5% |
| 2023 | $18.33 | -21.1% |
| 2022 | $23.23 | -73.3% |
Trading Range
The price is 5.9% below its 50-day average of $3.72 and 50.8% below its 200-day average of $7.12.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $3.50 | |
| 52-week high | $32.13 | -89.1% |
| 52-week low | $2.80 | +25.0% |
| 50-day average | $3.72 | -5.9% |
| 200-day average | $7.12 | -50.8% |
Price Risk
Over 3 years, its largest fall from a peak was 93.9%.
| Measure | Value |
|---|---|
| 1-year beta | 2.17 |
| Largest fall, 1 year | -90.6% |
| Largest fall, 3 years | -93.9% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About LENZ
What is LENZ's 1-year price change?
LENZ Therapeutics's price fell 86.3% over the past 12 months. With dividends included, the 12-month total return was -86.3%.
What is LENZ's 5-year price change?
LENZ Therapeutics's month-end price fell 96.6% over the 5 years through Oct 2026, a compound annual decline of 49.1%. These figures leave out dividends.
What is LENZ's 52-week high and low?
LENZ Therapeutics's 52-week high is $32.13 and its 52-week low is $2.80. Its latest price of $3.50 on Nov 17, 2026 is 89.1% below the high.
What is LENZ's beta?
LENZ Therapeutics's 1-year beta against the S&P 500 is 2.17, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 90.6%.
Is the LENZ chart free?
Yes. Advanced Charting for LENZ is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
LENZ pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors